Literature DB >> 3127369

Contribution of the microflora to proteolysis in the human large intestine.

G T Macfarlane1, C Allison, S A Gibson, J H Cummings.   

Abstract

Protease activities in human ileal effluent were approximately 20-fold greater than in normal faeces. Comparative studies with faeces from a person who did not have a pancreas suggested that a substantial proportion of the proteolytic activity in normal faeces was of bacterial origin. Thimerosal, iodoacetate, EDTA and cysteine significantly inhibited proteolysis in faeces, but not in small intestinal contents, showing that cysteine and metalloproteases were produced by bacteria in the large gut. These results, together with results from studies using p-nitroanilide substrates, demonstrated that faecal proteolysis was both qualitatively and quantitatively different from that in the small intestine. Studies with pure cultures of proteolytic gut bacteria indicated that the cell-bound proteases of Bacteroides fragilis-type organisms were likely to contribute significantly towards proteolytic activity associated with the washed cell fraction and washed particulate fraction of faeces. Extracellular proteases were formed by Streptococcus faecalis ST6, Propionibacterium acnes P6, Clostridium perfringens C16, Cl. bifermentans C21 and Cl. sporogenes C25. Inhibition results suggested that these bacteria, and similar organisms, may be partly responsible for the extracellular proteolytic activity found in the cell-free supernatant fraction of faeces.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3127369     DOI: 10.1111/j.1365-2672.1988.tb02427.x

Source DB:  PubMed          Journal:  J Appl Bacteriol        ISSN: 0021-8847


  61 in total

1.  Metabolism of azetirelin, a new thyrotropin-releasing hormone (TRH) analogue, by intestinal microorganisms.

Authors:  I Sasaki; T Tamura; T Shibakawa; T Fujita; M Murakami; A Yamamoto; S Muranishi
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

2.  Significance of microflora in proteolysis in the colon.

Authors:  S A Gibson; C McFarlan; S Hay; G T MacFarlane
Journal:  Appl Environ Microbiol       Date:  1989-03       Impact factor: 4.792

3.  Molecular form of faecal alpha 1 antitrypsin in patients with Crohn's disease.

Authors:  C Mizon; J eL Yamani; J Mizon; J F Colombel; A Cortot
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

4.  Physiological and nutritional factors affecting synthesis of extracellular metalloproteases by Clostridium bifermentans NCTC 2914.

Authors:  G T Macfarlane; S Macfarlane
Journal:  Appl Environ Microbiol       Date:  1992-04       Impact factor: 4.792

5.  Inactivation of tryptic activity by a human-derived strain of Bacteroides distasonis in the large intestines of gnotobiotic rats and mice.

Authors:  F Ramare; I Hautefort; F Verhe; P Raibaud; J Iovanna
Journal:  Appl Environ Microbiol       Date:  1996-04       Impact factor: 4.792

6.  Dietary Gluten as a Conditioning Factor of the Gut Microbiota in Celiac Disease.

Authors:  Karla A Bascuñán; Magdalena Araya; Leda Roncoroni; Luisa Doneda; Luca Elli
Journal:  Adv Nutr       Date:  2020-01-01       Impact factor: 8.701

Review 7.  Digestive Inflammation: Role of Proteolytic Dysregulation.

Authors:  Vincent Mariaule; Aicha Kriaa; Souha Soussou; Soufien Rhimi; Houda Boudaya; Juan Hernandez; Emmanuelle Maguin; Adam Lesner; Moez Rhimi
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

8.  Newly cultured bacteria with broad diversity isolated from eight-week continuous culture enrichments of cow feces on complex polysaccharides.

Authors:  Cherie J Ziemer
Journal:  Appl Environ Microbiol       Date:  2013-11-08       Impact factor: 4.792

Review 9.  Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications.

Authors:  Ian M Carroll; Nitsan Maharshak
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

10.  Colonic proteolysis following pancreatic duct ligation in the rat.

Authors:  D Bustos; O Tiscornia; M I Caldarini; G Negri; S Pons; K Ogawa; J A De Paula
Journal:  Int J Pancreatol       Date:  1994-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.